DENVER - ColoradoDesk -- Caliper CBD, the nation's leading brand of dissolvable CBD powder, is exasperated to announce that the results of Caliper CBD's regular batch testing by accredited third-party labs, known as Certificates of Analysis (COAs) will now be published on its website at [https://trycaliper.com/coa]. At the same time, Caliper CBD is releasing an eBook [https://trycaliper.com/wp-content/uploads/2020/...] and other content designed to help consumers interpret COAs in the context of CBD products. Why exasperated? Because COAs are technical documents designed for quality assurance professionals, not consumers. According to Justin Singer, CEO of Caliper CBD, "In the sixteen months since the 2018 Farm Bill was passed, the FDA has repeatedly refused to regulate consumer CBD products for quality, accuracy, and traceability. As a result, consumers have been left to fend for themselves in what can only be described as a 'Wild West' environment."

More on Colorado Desk

• New Partner at Itero Group Signals Continued Growth
• Travel + Leisure Readers give San Miguel De Allende a reason to Celebrate as it ranks in World's Best Awards
• MULTI-FUN project aims to enable multi-materials metal additive manufacturing for complex 3D parts without size constraints
• Sage Intacct Names Alta Vista Technology a Premier Partner
• Axiros AXESS ACS Enables UK ISP, Origin Broadband, With TR-069 Device Management Solution

In concert with the release of its COA functionality, Caliper CBD reminds consumers that each COA features its own specific analytical methods, levels of detection, and safety thresholds; that without FDA oversight there is no penalty for producing and disseminating an inaccurate COA; and that for the foregoing reasons, consumers should not treat any COA (including Caliper's) as proof of product quality, label accuracy, or food safety.

"Consumer-facing COAs are Food Safety Theater," said Singer, "These are technical documents meant for technical audiences, and it's absurd to hold consumers responsible for interpreting them. We are deeply concerned that FDA has let its desire to incentivize pharmaceutical innovation override its statutory duty to ensure the public health. Consumers should not be held responsible for detecting and avoiding latent defects in food and supplement products. That is FDA's job, and the longer they refuse to take responsibility for this space, the longer tens of millions of consumers will remain at risk."

Caliper CBD's COA page can be viewed online at trycaliper.com/coa. For more information, updates and recipes featuring Caliper CBD, visit the company's website, trycaliper.com, and follow the brand on Instagram @caliper.cbd.